glp-1 pill New Foundayo (Orforglipron) Gets FDA Approval for Obesity and turmeric extract standardized to 95% curcuminoids Why GLP-1 Weight-Loss Drugs Are

Following GLP-1 deprescription, patients weight did not significantly increase at 6 or 12 months post deprescription, compared to many well-known drug trials (in red) where patients regain up to two thirds of weight loss after discontinuing the drug

Neuropharmacology Cognitive dysfunction and metabolic comorbidities in mood disorders : A repurposing opportunity for glucagon-like peptide 1 receptor agonists

Those needing to optimize the bodys detoxification abilities

PMC , 2024.

10 GLP-1s also reduce visceral fat, the metabolically active fat stored around internal organs that feeds this cycle in the first place

Dysfunction of this process leads to the genetic disorders primary carnitine deficiency, carnitine palmitoyltransferase I deficiency, carnitine palmitoyltransferase II deficiency and carnitine-acylcarnitine translocase deficiency